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Potential Use of a Terbium - Transferrin Complex as a Label in an
lmmunoassay for Gentamicin
Nichola J. Wilmott, James N. Miller and Julian F. Tyson
Chemistry Department, Loughborough University of Technology, Loughborough, Leicestershire,
LEI I 3TU, UK

A study has been made of the potential use of a terbium - transferrin complex as a non-isotopic label in the
immunoassay determination of the antibiotic gentamicin. The fluorescence properties of the complex have
been characterised. The labelled gentamicin was formed using a controlled carbodiimide reaction, conditions
being chosen to produce a gentamicin-bound complex containing the correct amount of gentamicin for use in
a competitive binding assay. Recognition of the gentamicin-bound complex by antisera to gentamicin was
verified using a standard radioimmunoassay for gentamicin.
Keywords: Fluorescence immunoassa y; gentamicin assay; terbium - transferrin label

The last decade has seen several attempts to develop
non-isotopic immunoassays with a view to replacing radioimmunoassay methods which have many well documented
disadvantages.
Several approaches have been made to the use of metal ions
as labels in immunoassay: CaislJ used derivatives of sandwich
compounds such as ferrocene to label steroids and other
molecules, detection of the labelled species being carried out
by atomic-absorption spectrometry. These labels were relatively insensitive in immunoassays, no doubt partly because
the metals used (Fe, Mn, etc.) occur at high concentrations in
biological samples. Cais subsequently synthesised metallohaptens by the mercuration of steroid estrogens,3 where the
metal atoms were introduced directly into the molecule of the
antigen, and by the formation of cymatrene complexes
containing manganese.4 Leuvering et al.5 have studied the use
of colloidal coating with atomic-absorption spectrometric
determination.
In this paper we report the potential use of lanthanide ions
as labels in immunoassay. In principle, lanthanide ion
complexes should form useful labels in immunoassay as they
are highly fluorescent and the concentration of lanthanide ions
in biological samples is extremely low. In particular, a study
has been made of the potential of the complex between
terbium and transferrin as a label in the immunoassay of
gentamicin.
Human serum transferrin has the function in the body of
binding and transporting iron in the plasma in the form of
Fe3+. Transferrin binds two iron(II1) ions per molecule in
specific sites on the polypeptide chain, but in the absence of
iron these sites may be occupied by lanthanide ions to form
highly fluorescent complexes.
Gentamicin is an aminoglycosidic antibiotic used in the
treatment of severe Gram-negative bacteria. Its optimum
therapeutic concentration in human serum is 4-12 mg 1-1
(9-20 pmol I - l ) , maintained by intramuscular injection:
0.8 mg per kilogram body mass every 8 h. It is extremely
effective but has a low therapeutic ratio and therefore its level
must be monitored by a simple, rapid and reliable method.

Experimental
Apparatus
All fluorescence spectra were measured on a Perkin-Elmer
Model LS-5 luminescence spectrometer fitted with an R928
photomultiplier. Data were recorded using a Perkin-Elmer
Model 3600 data station using PECLS I1 applications software, which permitted the calculation of corrected spectra and
phosphorescence lifetimes.

Reagents
Terbium chloride and glycine were obtained from Aldrich
Chemical Co. and iron-free transferrin, gentamicin sulphate
and l-ethyl-3-(3-dimethylaminopropyl)carbodiimidehydrochloride from Sigma London Chemical Co.
All radioimmunoassays were carried out using a radioimmunoassay kit supplied by RIA (UK) Ltd.
Antibodies used in the antibody binding experiments were
supplied by Sigma Chemical Co. Ltd.

Fluorescence of Terbium and the Terbium
Complex

-

Transferrin

Fluorescence spectra of terbium chloride in aqueous solution
and a terbium - transferrin complex in Tris - hydrochloric acid hydrogen carbonate buffer6 were recorded.
The limits of detection of the complex and its fluorescence
lifetime (the time for the fluorescence of a sample to decay to
the background level) were also determined.
The complex for the above experiments was prepared by the
addition of aqueous terbium chloride to iron-free transferrin
in Tris - hydrochloric acid - hydrogen carbonate buffer in the
molar ratio 2 : 1.

Linkage of Gentamicin to Transferrin
The linkage of gentamicin to transferrin was achieved using a
carbodiimide reagent. In this procedure a free acid group on
the transferrin molecule is linked to a free amino group on the
gentamicin. Experiments were carried out using 1-ethyl-3-(3dimethylaminopropy1)carbodiimide hydrochloride in aqueous
solution.
Iron-free transferrin (30 mg), gentamicin (60 mg) and the
carbodiimide (400 mg) were incubated at room temperature in
distilled water (2.5 ml) for varying lengths of time before
separation of the protein fraction on a Sephadex G-25 column
by elution with Tris - hydrochloric acid - hydrogen carbonate
buffer (pH 8.5). Verification of gentamicin binding was
carried out using 125I-labelled gentamicin.
The carbodiimide procedure was repeated using various
glycine to gentamicin ratios for the gentamicin in the original
experiment, the reaction time being 5 min in each instance.
The reaction products were subsequently analysed for their
gentamicin content by radioimmunoassay and their fluorescence was measured after terbium binding.
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Table 1. Results of analysis of complex for gentamicin by
radioimmunoassay
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Fig. 1.

Emission spectra of terbium chloride and a terbium transferrin complex. l, 10-5 M terbium - transferrin compl ex; and 2,
100 mM terbium chloride

Analyte
0 µgml- 1 standard
1 µgml- 1 standard
2 µgml-1 standard
4µgml - 1 standard
8µgml-1 standard
16µgml-1 standard
Glycine : gentamicin rati�
0:20
2: 18
5: 15
10: 10
15:5
18:2

C.p .s.
42 039
36 557
28 737
16 771
9 860
6 481
1 023
540
1 073
1870
7 497
11 493

j

>16
8-16
4-8

Table 2. Results of stability tests on the glycine - gentamicin bound

complex

8C:

"'f:?
Q)
u

0::,

u:::

0

=="""'=....____

450

500

....._..L_L:.__ ,._,___,,,,________--...J

550

600

Emission wavelength/nm

650

700

I:ig. 2.

Emission spectra of 1: 100 human serum with various delay
times: l, 0.01; 2, 0.02; and 3, 0.05 ms

Titration of the Gentamicin - Glycine Bound Complex against
Anti-gentamicin

The effect on the fluorescence of the complex in various
concentrations of antiserum to gentarnicin (raised in rabbit)
was investigated using the double antibody technique with
anti-rabbit IgG. Fluorescence measurements were taken
following incubation, precipitation and centrifugation.

Results and Discussion
Fluorescence of Terbium and the Terbium · Transferrin
Complex

Fig. 1 shows an enhancement of the fluorescence intensity of
terbium of the order of 105 when the complex is excited at 295
nm. This fluorescence enhancement is due to an intramole
cular energy transfer process within the complex. This is
demonstrated by the fact that the complex excitation is in the
region of the ligand absorbing region whereas the emission is
typical of the "line" emission of the terbium ion.
The limit of detection of the complex was shown to be 10- 7
M with respect to transferrin, a result which suggests that the
complex has a suitable fluorescence intensity for use as a label
in the analysis of drugs by immunoassay.
The complex had a lifetime of 1.25 ms. Subsequent delayed
fluorescence experiments (Fig. 2) showed that interference
due to scattered light from blood serum could be reduced to
zero with a delay gate of 0.05 ms. The subsequent decrease in
fluorescence intensity of the complex was l�ss than 5%. The
following instrumental conditions were thus chosen: excita
tion slit, 5.0 nm; emission slit, 5.0 nm; excitation wavelength,
295 nm; delay time, 0.05 ms; gate time, 5.0 ms; and fixed-scale
mode.

Time after
formation
Omin
5min
lOmin
15min
30min
45min
lh
24h
7d

Fluorescence Fluorescence
intensity in
intensity in
1: lOOserum
buffer
104.95
64.19
67.48
109.55
71. 19
103.50
72.84
104.25
74.07
107.10
74.80
106.20
77.45
107.05
77.46
109.00
77.46
110.95

Linkage of Gentamicin to Transferrin

The experiments carried out using 12s1.1abelled gentamicin
showed that with reaction times from 5 min to 1 h substantial
gentamicin binding was occurring.
Analysis of the Gentamicin Content of Complexes with
Substituted Glycine

Table 1 shows the amount of gentamicin bound per millilitre
of solution for various reaction mixtures as analysed by
standard radioimmunoassay for gentamicin.
It can be seen that gentamicin - glycine bound complexes
with glycine to gentamicin ratios of less than 15 : 5 have too
high a gentamicin content for use in a competitive binding
assay for the therapeutic blood concentration range of
gentamicin (4--12 µg ml-1).
Fluorescence measurements on the complexes modified by
glycine and gentamicin showed a decrease in fluorescence
intensity of less than 5% compared with the original terbium transferrin complex.
Stability of the Gentamicin - Glycine Bound Complex

It can be seen from Table 2 that a complex containing a glycine
to gentamicin ratio of 9 : 1 is stable in buffer and buffer
containing 1 : 100 human serum over a period of at least 7 d.
Absorbance measurements at 295 nm showed that the
decrease in fluorescence intensity in 1 : 100 serum was due to
the increased absorbance of the solution at that wavelength.
Titration of the Glycine - Gentamicin Complex against
Anti-gentamicin

Titration of the complex against anti-gentamicin (Fig. 3)
shows good antibody recognition of the complex, the curve
shape being typical of such a dilution analysis.
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respect. The bifunctional reagents that would be suitable are
of the type described by Meares and co-workers,9 11J which
have "EDT A" groups and groups suitable for binding to
amino acids at opposite extremities of the molecule. Another
alternative is the use of bifunctional reagents where the
chelating agent is "iminodiacetic acid. "11 12
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Fig. 3. Antibody dilution analysis of the terbium
gentamicin - glycine complex

transfcrrin

Conclusion
The results suggest that a glycine - gentamicin bound terbium transferrin complex has potential as a non-isotopic immunoas
say label. However, it is felt that careful consideration should
be given to the final format of the immunoassay, owing to
possible effects of the macromolecular label. At present the
most suitable separation methods are being established.
Although the terbium - transferrin complex shows potential
as an alternative label in immunoassay, it has the disadvantage
of sensitivity suitable only for the detection of drugs and not
hormones. One means of increasing the sensitivity is to
increase the fluorescence intensity. Further study of the
intramolecular energy transfer process7 -8 such as are involved
in the terbium - transferrin complex might prove useful in this
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